Just published…With ~50% patients not requiring additional treatment for 9 mon…
Just published…With ~50% patients not requiring additional treatment for 9 months after the last CLS-TA treatment, demonstrates the potential for durability with the suprachoroidal platform & small molecule suspensions such as CLS-TA. #retina #eyes https://t.co/JRiSW8r5ht Source by Thomas Ciulla, MD, MBA Return to main website.